{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Oncology+Care&page=13", "query": { "intervention": "Standard Oncology Care", "page": 13 }, "page_size": 10 }, "pagination": { "page": 13, "page_size": 10, "total_count": 3313, "total_pages": 332, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Oncology+Care&page=14&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Oncology+Care&page=12&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T14:52:33.031Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01360840", "title": "EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer Metastatic" ], "interventions": [ { "name": "EMD 525797", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Standard of Care (SoC)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "EMD Serono", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 180, "start_date": "2011-04", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2015-12-14", "last_synced_at": "2026-10-14T14:52:33.031Z", "location_count": 12, "location_summary": "Pleasant Hill, California • Chicago, Illinois • New Orleans, Louisiana + 9 more", "locations": [ { "city": "Pleasant Hill", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01360840" }, { "nct_id": "NCT06258525", "title": "SAMe in Prevention of Oxaliplatin-associated Liver Injury", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Cancer", "Liver Metastases", "Liver Metastasis Colon Cancer", "Liver Injury", "Sinusoidal Obstruction Syndrome", "5-Fluorouracil Toxicity", "Liver Toxicity, Chemically-Induced" ], "interventions": [ { "name": "Standard of care oxaliplatin-based chemotherapy", "type": "RADIATION" }, { "name": "S-adenosylmethionine (SAMe) supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "RADIATION", "DIETARY_SUPPLEMENT", "PROCEDURE" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2026-10", "completion_date": "2028-10", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-14T14:52:33.031Z", "location_count": 2, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06258525" }, { "nct_id": "NCT04986579", "title": "Scalp Cooling in MBC", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Breast Cancer", "Chemotherapy-induced Alopecia" ], "interventions": [ { "name": "Paxman Scalp Cooling System", "type": "DEVICE" }, { "name": "Eribulin", "type": "DRUG" }, { "name": "Sacituzumab govitecan", "type": "DRUG" }, { "name": "Trastuzumab deruxtecan", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2021-10-07", "completion_date": "2030-06-01", "has_results": false, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-10-14T14:52:33.031Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04986579" }, { "nct_id": "NCT01804179", "title": "Colorectal Cancer Awareness, Research, Education and Screening (CARES)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "Immunochemical Fecal Occult Blood Test (I-FOBT) Kit", "type": "OTHER" }, { "name": "Standard Intervention (SI) Educational Materials", "type": "OTHER" }, { "name": "CARES Intervention Educational Materials", "type": "OTHER" }, { "name": "Baseline Visit Survey", "type": "OTHER" }, { "name": "Follow-up Questionnaire", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "50 Years to 75 Years" }, "enrollment_count": 514, "start_date": "2011-02-11", "completion_date": "2022-09-09", "has_results": false, "last_update_posted_date": "2022-09-10", "last_synced_at": "2026-10-14T14:52:33.031Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01804179" }, { "nct_id": "NCT03521141", "title": "PRecision Interventions for SMoking in the SCCS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Tobacco Use Cessation" ], "interventions": [ { "name": "Nicotine patch", "type": "DRUG" }, { "name": "Varenicline", "type": "DRUG" }, { "name": "Nicotine metabolism", "type": "GENETIC" }, { "name": "Genetically-informed lung cancer risk score", "type": "GENETIC" }, { "name": "NCI \"Clearing the Air\"", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "GENETIC", "BEHAVIORAL" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 67, "start_date": "2018-05-18", "completion_date": "2019-04-25", "has_results": true, "last_update_posted_date": "2020-06-01", "last_synced_at": "2026-10-14T14:52:33.031Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03521141" }, { "nct_id": "NCT04350788", "title": "Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Survivorship Care Plan", "type": "OTHER" }, { "name": "Enhanced Survivorship Care Plan", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 124, "start_date": "2017-08-03", "completion_date": "2019-04-15", "has_results": true, "last_update_posted_date": "2020-09-23", "last_synced_at": "2026-10-14T14:52:33.031Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04350788" }, { "nct_id": "NCT04331041", "title": "Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pancreas Cancer", "Cancer of the Pancreas", "Pancreas Adenocarcinoma" ], "interventions": [ { "name": "Adaptive stereotactic body radiation therapy", "type": "DEVICE" }, { "name": "Defactinib", "type": "DRUG" }, { "name": "Tumor biopsy", "type": "PROCEDURE" }, { "name": "Research blood draw", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "DRUG", "PROCEDURE" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2021-08-24", "completion_date": "2027-04-21", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-10-14T14:52:33.031Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04331041" }, { "nct_id": "NCT06732388", "title": "Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Barrett Esophagus", "Clinical Stage I Esophageal Adenocarcinoma AJCC v8", "Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8", "Esophageal Adenocarcinoma" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Endoscopic Procedure", "type": "PROCEDURE" }, { "name": "Itraconazole", "type": "DRUG" }, { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Radiofrequency Ablation", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 76, "start_date": "2026-06-23", "completion_date": "2030-12-01", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-10-14T14:52:33.031Z", "location_count": 6, "location_summary": "Kansas City, Kansas • Ann Arbor, Michigan • St Louis, Missouri + 3 more", "locations": [ { "city": "Kansas City", "state": "Kansas" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06732388" }, { "nct_id": "NCT04322643", "title": "Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Urothelial Carcinoma" ], "interventions": [ { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Durvalumab", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" }, { "name": "Avelumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2020-03-23", "completion_date": "2023-04-17", "has_results": true, "last_update_posted_date": "2025-02-25", "last_synced_at": "2026-10-14T14:52:33.031Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04322643" }, { "nct_id": "NCT06576115", "title": "Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Pancreatic Adenocarcinoma" ], "interventions": [ { "name": "Nab paclitaxel", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "TheraBionic P1", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Barbara Ann Karmanos Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2025-02-28", "completion_date": "2027-07", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-14T14:52:33.031Z", "location_count": 7, "location_summary": "Clarkston, Michigan • Detroit, Michigan • Flint, Michigan + 4 more", "locations": [ { "city": "Clarkston", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Flint", "state": "Michigan" }, { "city": "Lansing", "state": "Michigan" }, { "city": "Lapeer", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06576115" } ] }